Skip to main content
HR 6429 116th Congress House Health Advisory bodies Cardiovascular and respiratory health Congressional operations and organization Emergency medical services and trauma care Federal-Indian relations First responders and emergency personnel Health facilities and institutions Health personnel Health programs administration and funding Health promotion and preventive care Health technology, devices, supplies Immunology and vaccination Infectious and parasitic diseases Intergovernmental relations International organizations and cooperation Long-term, rehabilitative, and terminal care Medical tests and diagnostic methods Military procurement, research, weapons development Public contracts and procurement

National Commission on COVID-19 Act

Introduced: April 3, 2020 See on congress.gov
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 6, 2020
Referred to the Subcommittee on Economic Development, Public Buildings, and Emergency Management.
Apr 3, 2020
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Financial Services, and Transportation and Infrastructure, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 3, 2020
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

National Commission on COVID-19 Act

This bill establishes the National Commission on COVID-19 (i.e., coronavirus disease 2019) in the legislative branch to assess the emergence, spread, and response to the disease in the United States and sets forth its powers, duties, funding, and membership. The commission must issue a report with findings and recommendations concerning, among other topics,

  • surveillance, testing, treatment, and vaccines;
  • medical devices, drugs, and other supplies, including personal protective equipment;
  • preparedness and capacity of the U.S. health care system;
  • certain federal laws and programs such as the Defense Production Act, the Strategic National Stockpile, and others;
  • public health measures such as social distancing; and
  • roles and responsibilities among federal departments, as well as coordination and communication between those departments and other entities, including state, territorial, tribal, and local governments.

The commission terminates 60 days after the submission of the final report.

What's happening now April 6, 2020

Referred to the Subcommittee on Economic Development, Public Buildings, and Emergency Management.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 6429: National Commission on COVID-19 Act. 116th Congress. Open America. https://openamerica.io/bill/116-HR-6429/
MLA
"H.R. 6429: National Commission on COVID-19 Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-6429/.
Bluebook (legal)
H.R. 6429, 116th Cong. (2026), https://openamerica.io/bill/116-HR-6429/.
Markdown link
[H.R. 6429: National Commission on COVID-19 Act](https://openamerica.io/bill/116-HR-6429/)
Report a problem